Rejuvenate
发表于 2025-3-23 11:02:39
http://reply.papertrans.cn/67/6673/667291/667291_11.png
FANG
发表于 2025-3-23 16:39:01
Progress in cardiac positron emission tomography with emphasis on carbon-11 labeled palmitate and oto injury is limited. In consequence, anatomic or functional descriptions do not necessarily reflect the diversity of the underlying processes. Cardiac positron emission tomography (PET) is being developed in part to assess the biochemical processes which underlie such disorders.
尊重
发表于 2025-3-23 21:22:15
http://reply.papertrans.cn/67/6673/667291/667291_13.png
裹住
发表于 2025-3-23 22:57:29
http://reply.papertrans.cn/67/6673/667291/667291_14.png
蒸发
发表于 2025-3-24 04:39:26
http://reply.papertrans.cn/67/6673/667291/667291_15.png
刻苦读书
发表于 2025-3-24 07:10:14
Developments in Cardiovascular Medicinehttp://image.papertrans.cn/n/image/667291.jpg
Benzodiazepines
发表于 2025-3-24 10:44:32
https://doi.org/10.1007/978-94-009-3287-6assessment; cardiology; cardiovascular; development; evaluation; fat; heart; imaging; magnetic resonance spe
KIN
发表于 2025-3-24 18:14:35
978-94-010-7976-1Martinus Nijhoff Publishers, Dordrecht 1987
留恋
发表于 2025-3-24 21:00:46
Noninvasive Imaging of Cardiac Metabolism978-94-009-3287-6Series ISSN 0166-9842
NIP
发表于 2025-3-25 01:48:43
Radiopharmaceuticals for cardiovascular nuclear medicine,y research centers that have medical cyclotron facilities. The cardiovascular radiopharmaceuticals can be divided into six major groups: 1) tracers for cardiac blood pool studies; 2) agents for perfusion scintigraphy; 3) metabolic substrates and their analogs; 4) infarct avid agents; 5) specific car